Costs and utilization of hemophilia A and B patients with and without inhibitors

Figures & data

Table 1. Demographic and baseline characteristics.

Characteristic	Number (%) of patients (N = 214)
Hemophilia type
A	160 (74.8)
B	54 (25.2)
Patients with inhibitors
Hemophilia A	5 (3.1)
Hemophilia B	2 (3.7)
Age, median (range), years
Patients with inhibitors	2.0 (<1–11)
Hemophilia A without inhibitors	6.0 (<1–43)
Hemophilia B without inhibitors	8.5 (<1–61)

Figure 1. Percentage of patients with at least one hospitalization within 5 years by inhibitor status.

Figure 2. Median aggregate overall healthcare costs per year by inhibitor status.